{"id":"https://openalex.org/W2741097928","doi":"https://doi.org/10.1158/1538-7445.am2017-ct150","title":"Abstract CT150: Optimizing the therapeutic index of HDM2 inhibition: Results from a dose- and regimen-finding Phase I study of NVP-HDM201 in pts with TP53 wt advanced tumors","display_name":"Abstract CT150: Optimizing the therapeutic index of HDM2 inhibition: Results from a dose- and regimen-finding Phase I study of NVP-HDM201 in pts with TP53 wt advanced tumors","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2741097928","doi":"https://doi.org/10.1158/1538-7445.am2017-ct150","mag":"2741097928"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-ct150","doi":"https://doi.org/10.1158/1538-7445.am2017-ct150","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-ct150","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068193017","display_name":"David Michael Hyman","orcid":"https://orcid.org/0000-0001-8150-9762","observed_orcids":["https://orcid.org/0000-0001-8150-9762"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David M. Hyman","raw_affiliation_strings":["1Memorial Sloan Kettering Cancer Center, New York City, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Memorial Sloan Kettering Cancer Center, New York City, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080827305","display_name":"Manik Chatterjee","orcid":"https://orcid.org/0000-0001-7854-5543","observed_orcids":["https://orcid.org/0000-0001-7854-5543"]},"institutions":[{"id":"https://openalex.org/I4210126310","display_name":"Universit\u00e4tsklinikum W\u00fcrzburg","ror":"https://ror.org/03pvr2g57","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210126310"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Manik Chatterjee","raw_affiliation_strings":["2University Hospital of W\u00fcrzburg, W\u00fcrzburg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University Hospital of W\u00fcrzburg, W\u00fcrzburg, Germany;","institution_ids":["https://openalex.org/I4210126310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029982164","display_name":"Filip De Vos","orcid":"https://orcid.org/0000-0002-9082-5991","observed_orcids":["https://orcid.org/0000-0002-9082-5991"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Filip de Vos","raw_affiliation_strings":["3UMC Utrecht Cancer Center, Utrecht, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3UMC Utrecht Cancer Center, Utrecht, Netherlands;","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112421072","display_name":"Chia\u2010Chi Lin","orcid":"https://orcid.org/0000-0002-2573-5789","observed_orcids":["https://orcid.org/0000-0002-2573-5789","https://orcid.org/0009-0006-5084-0819"]},"institutions":[{"id":"https://openalex.org/I4210131804","display_name":"National Taiwan University Hospital","ror":"https://ror.org/03nteze27","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210131804"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Chia-Chi Lin","raw_affiliation_strings":["4National Taiwan University Hospital, Taipei, Taiwan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4National Taiwan University Hospital, Taipei, Taiwan;","institution_ids":["https://openalex.org/I4210131804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079620361","display_name":"Cristina Su\u00e1rez","orcid":"https://orcid.org/0000-0002-0502-5528","observed_orcids":["https://orcid.org/0000-0002-0502-5528"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cristina Su\u00e1rez","raw_affiliation_strings":["5Vall d'Hebron University Hospital and Institute of Oncology, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Vall d'Hebron University Hospital and Institute of Oncology, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain;","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089860988","display_name":"David Wai-Meng Tai","orcid":"https://orcid.org/0000-0002-2612-0065","observed_orcids":["https://orcid.org/0000-0002-2612-0065"]},"institutions":[{"id":"https://openalex.org/I4210137145","display_name":"National Cancer Centre Singapore","ror":"https://ror.org/03bqk3e80","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I4210137145"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"David Tai","raw_affiliation_strings":["6National Cancer Centre Singapore, Singapore, Singapore;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6National Cancer Centre Singapore, Singapore, Singapore;","institution_ids":["https://openalex.org/I4210137145"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027371764","display_name":"Philippe Alexandre Cassier","orcid":"https://orcid.org/0000-0003-3857-1688","observed_orcids":["https://orcid.org/0000-0003-3857-1688"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Cassier","raw_affiliation_strings":["7Centre L\u00e9on B\u00e9rard, Lyon, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Centre L\u00e9on B\u00e9rard, Lyon, France;","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030587345","display_name":"Noboru Yamamoto","orcid":"https://orcid.org/0000-0002-0787-2851","observed_orcids":["https://orcid.org/0000-0002-0787-2851"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Noboru Yamamoto","raw_affiliation_strings":["8National Cancer Center Hospital, Tokyo, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8National Cancer Center Hospital, Tokyo, Japan;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006165743","display_name":"Vincent A. de Weger","orcid":"https://orcid.org/0000-0002-1658-9222","observed_orcids":["https://orcid.org/0000-0002-1658-9222"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Vincent A. de Weger","raw_affiliation_strings":["9Netherlands Cancer Institute, Amsterdam, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Netherlands Cancer Institute, Amsterdam, Netherlands;","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048381149","display_name":"S\u00e9bastien Jeay","orcid":"https://orcid.org/0000-0001-7476-3340","observed_orcids":["https://orcid.org/0000-0001-7476-3340"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"S\u00e9bastien Jeay","raw_affiliation_strings":["10Novartis Institutes for BioMedical Research, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Novartis Institutes for BioMedical Research, Basel, Switzerland;","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077835854","display_name":"Christophe Meille","orcid":"https://orcid.org/0000-0001-8573-1248","observed_orcids":["https://orcid.org/0000-0001-8573-1248"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Christophe Meille","raw_affiliation_strings":["10Novartis Institutes for BioMedical Research, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Novartis Institutes for BioMedical Research, Basel, Switzerland;","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002902099","display_name":"Ensar Halilovic","orcid":"https://orcid.org/0000-0001-6017-4094","observed_orcids":["https://orcid.org/0000-0001-6017-4094"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ensar Halilovic","raw_affiliation_strings":["11Novartis Institutes for BioMedical Research, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Novartis Institutes for BioMedical Research, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046622402","display_name":"Luisa Mariconti","orcid":"https://orcid.org/0009-0000-2154-2704","observed_orcids":["https://orcid.org/0009-0000-2154-2704"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Luisa Mariconti","raw_affiliation_strings":["10Novartis Institutes for BioMedical Research, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Novartis Institutes for BioMedical Research, Basel, Switzerland;","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027733078","display_name":"Matthieu Klopfenstein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Matthieu Klopfenstein","raw_affiliation_strings":["10Novartis Institutes for BioMedical Research, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Novartis Institutes for BioMedical Research, Basel, Switzerland;","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112724274","display_name":"Nelson Guerreiro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]},{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Nelson Guerreiro","raw_affiliation_strings":["10Novartis Institutes for BioMedical Research, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Novartis Institutes for BioMedical Research, Basel, Switzerland;","institution_ids":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045558765","display_name":"Rajkumar Radhakrishnan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090302","display_name":"Novartis (India)","ror":"https://ror.org/00dhvr506","country_code":"IN","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210090302"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Rajkumar Radhakrishnan","raw_affiliation_strings":["12Novartis Healthcare Pvt. Ltd, Hyderabad, India;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12Novartis Healthcare Pvt. Ltd, Hyderabad, India;","institution_ids":["https://openalex.org/I4210090302"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037407982","display_name":"Emil Tom Kuriakose","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emil T. Kuriakose","raw_affiliation_strings":["13Novartis Institutes for BioMedical Research, East Hanover, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Novartis Institutes for BioMedical Research, East Hanover, NJ;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031540987","display_name":"Sebastian Bauer","orcid":"https://orcid.org/0000-0001-5949-8120","observed_orcids":["https://orcid.org/0000-0001-5949-8120"]},"institutions":[{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sebastian Bauer","raw_affiliation_strings":["14West German Cancer Center, University of Duisburg-Essen, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14West German Cancer Center, University of Duisburg-Essen, Essen, Germany","institution_ids":["https://openalex.org/I62318514"]}]}],"institutions":[],"countries_distinct_count":9,"institutions_distinct_count":14,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"CT150","last_page":"CT150"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/wild-type-p53","display_name":"wild-type p53","score":0.8769999742507935},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8880000114440918},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.5809999704360962},{"id":"https://openalex.org/keywords/treatment-regimens","display_name":"treatment regimens","score":0.621999979019165},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8119999766349792},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9369999766349792},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9679999947547913},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.5580000281333923},{"id":"https://openalex.org/keywords/gastrointestinal-toxicity","display_name":"gastrointestinal toxicity","score":0.671999990940094},{"id":"https://openalex.org/keywords/therapeutic-index","display_name":"therapeutic index","score":0.3869999945163727},{"id":"https://openalex.org/keywords/mdm2-inhibitors","display_name":"MDM2 inhibitors","score":0.39800000190734863},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.4909999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8063013553619385},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7596017718315125},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6630862951278687},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.5317415595054626},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5244320034980774},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5214087963104248},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.478158563375473},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.45616844296455383},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.32960158586502075},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3285643756389618},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3253323435783386},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.322529137134552},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3054761290550232}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-ct150","doi":"https://doi.org/10.1158/1538-7445.am2017-ct150","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-ct150","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2740931579","https://openalex.org/W2560489757","https://openalex.org/W2499033683","https://openalex.org/W2588711404","https://openalex.org/W3203259359","https://openalex.org/W2476928531","https://openalex.org/W3172574127","https://openalex.org/W1997477416","https://openalex.org/W2797465271","https://openalex.org/W4252049965"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"NVP-HDM201":[2,42,100,177,357,376,436,455,528],"is":[3,350,441,461],"a":[4,117,131,149,162,378,386,451,520],"selective":[5],"inhibitor":[6],"of":[7,41,99,167,268,368,394,417,449,515,527,539],"the":[8,36,168,231,254,320,334,353,369,403,409,414,438,445,512,540],"p53-HDM2":[9],"interaction,":[10],"and":[11,21,39,121,128,134,152,225,250,291,308,316,349,362,382,396,437,447,464,522],"has":[12],"demonstrated":[13,377],"potent":[14],"single-agent":[15,93],"activity":[16,384],"in":[17,19,22,116,130,148,161,237,283,288,293,305,311,385,529],"various":[18],"vitro":[20],"vivo":[23],"tumor":[24,342],"models":[25],"dependent":[26],"on":[27,80,113,125,372],"wild-type":[28],"(wt)":[29],"TP53.":[30],"This":[31],"study":[32,526],"aims":[33],"to":[34,202,333,458],"determine":[35],"optimal":[37],"dose":[38,111,235,252,428],"schedule":[40],"for":[43,51,84,144,158,341,402,429,543],"treating":[44],"patients":[45],"(pts)":[46],"with":[47,61,74,92,327,345,352,365,456,531],"TP53":[48,76,532],"wt":[49,77,533],"tumors":[50,78,535],"further":[52],"clinical":[53,355,383],"study.":[54],"Here":[55],"we":[56],"report":[57],"results":[58],"from":[59,519],"pts":[60,73,175,239,286,303,530],"solid":[62],"tumors.":[63],"Methods:":[64],"In":[65],"this":[66],"multicenter,":[67],"open-label,":[68],"Phase":[69,524],"I,":[70],"ongoing":[71],"study,":[72],"advanced":[75,534],"progressing":[79],"standard":[81,87],"therapy":[82,88],"or":[83],"whom":[85],"no":[86],"exists":[89],"were":[90,191,234,281],"treated":[91],"oral":[94],"NVP-HDM201.":[95],"Four":[96],"treatment":[97,204],"regimens":[98,272],"are":[101],"explored:":[102],"two":[103,135,233],"high-dose":[104],"intermittent":[105],"regimens,":[106,138],"Regimen":[107],"(Reg)":[108],"1A":[109,179,290],"(single":[110],"[SD]":[112],"Day":[114],"1":[115,127,292],"3-week":[118],"[wk]":[119],"cycle)":[120,151],"Reg":[122,139,153,181,184,187,208,210,212,289,294,306,312,314,317,328,346,398],"1B":[123,182,330,399],"(SD":[124,141,155],"Days":[126],"8":[129],"4-wk":[132,150,163],"cycle);":[133],"low-dose":[136],"extended":[137],"2A":[140,185,315],"every":[142,156],"day":[143,157,373],"first":[145,159,232],"2":[146,284],"wks":[147],"2C":[154,188],"wk":[160],"cycle).":[164],"Results:":[165],"As":[166],"data":[169],"cut-off":[170],"(Sep":[171],"19,":[172],"2016),":[173],"85":[174],"received":[176],"(Reg":[178,206],"n=26;":[180],"n=20;":[183,186],"n=19);":[189],"13%":[190],"still":[192],"receiving":[193],"treatment.":[194],"Common":[195],"Grade":[196,418],"3/4":[197,419],"adverse":[198],"events":[199],"(AEs)":[200],"suspected":[201],"be":[203,466],"related":[205],"1A;":[207],"1B;":[209],"2A;":[211],"2C)":[213],"included":[214],"neutropenia":[215,395],"(23%;":[216,221],"25%;":[217],"15%;":[218],"5%),":[219],"thrombocytopenia":[220,420,460],"10%;":[222],"20%;":[223,229],"11%),":[224],"anemia":[226],"(12%;":[227],"0%;":[228],"16%);":[230],"limiting":[236],"4":[238],"(2;":[240],"1;":[241],"0;":[242],"1).":[243],"Gastrointestinal":[244],"toxicity":[245],"was":[246,260,273,298,331,400,431],"predominantly":[247],"low":[248],"grade,":[249],"not":[251],"limiting;":[253],"most":[255,410],"common":[256],"treatment-related":[257],"AE":[258],"reported":[259],"nausea":[261],"(62%;":[262],"60%;":[263],"40%;":[264],"42%).":[265],"Median":[266],"duration":[267],"exposure":[269,363],"across":[270],"all":[271],"8.5":[274],"weeks":[275],"(range:":[276],"2-86":[277],"weeks).":[278],"Partial":[279],"responses":[280],"observed":[282,354],"(2%)":[285],"(1":[287],"1B).":[295],"Stable":[296],"disease":[297],"achieved":[299,408],"by":[300],"29":[301],"(34%)":[302],"(8":[304],"1A,":[307],"7":[309],"each":[310],"1B,":[313],"2C).":[318],"Furthermore,":[319],"average":[321],"plasma":[322],"concentration":[323],"per":[324],"cycle":[325],"reached":[326],"1A/Reg":[329],"closer":[332],"predicted":[335],"preclinical":[336],"target":[337],"efficacious":[338],"levels":[339],"required":[340],"regression":[343],"compared":[344],"2A/Reg":[347],"2C,":[348],"associated":[351],"activity.":[356],"showed":[358],"approximate":[359],"dose-proportional":[360],"pharmacokinetics,":[361],"correlated":[364],"blood":[366],"concentrations":[367],"GDF-15":[370],"biomarker":[371],"1.":[374],"Conclusions:":[375],"manageable":[379],"safety":[380,446],"profile":[381],"heavily":[387],"pretreated":[388],"population.":[389],"Dose-limiting":[390],"toxicities":[391],"consisted":[392],"primarily":[393],"thrombocytopenia.":[397],"chosen":[401],"expansion":[404,430,439],"phase":[405,440],"as":[406,433],"it":[407],"favorable":[411],"therapeutic":[412,513],"index:":[413],"lowest":[415],"incidence":[416],"while":[421],"achieving":[422],"therapeutically":[423],"relevant":[424],"exposures.":[425],"The":[426],"recommended":[427],"declared":[432],"120":[434],"mg":[435],"enrolling.":[442],"To":[443],"enhance":[444],"efficacy":[448],"NVP-HDM201,":[450],"separate":[452],"cohort":[453],"combining":[454],"eltrombopag":[457],"mitigate":[459],"being":[462],"investigated":[463],"will":[465],"reported.":[467],"Citation":[468],"Format:":[469],"David":[470,482],"M.":[471],"Hyman,":[472],"Manik":[473],"Chatterjee,":[474],"Filip":[475],"de":[476,490],"Vos,":[477],"Chia-Chi":[478],"Lin,":[479],"Cristina":[480],"Su\u00e1rez,":[481],"Tai,":[483],"Philippe":[484],"Cassier,":[485],"Noboru":[486],"Yamamoto,":[487],"Vincent":[488],"A.":[489],"Weger,":[491],"S\u00e9bastien":[492],"Jeay,":[493],"Christophe":[494],"Meille,":[495],"Ensar":[496],"Halilovic,":[497],"Luisa":[498],"Mariconti,":[499],"Matthieu":[500],"Klopfenstein,":[501],"Nelson":[502],"Guerreiro,":[503],"Rajkumar":[504],"Radhakrishnan,":[505],"Emil":[506],"T.":[507],"Kuriakose,":[508],"Sebastian":[509],"Bauer.":[510],"Optimizing":[511],"index":[514],"HDM2":[516],"inhibition:":[517],"Results":[518],"dose-":[521],"regimen-finding":[523],"I":[525],"[abstract].":[536],"In:":[537],"Proceedings":[538],"American":[541],"Association":[542],"Cancer":[544,557],"Research":[545],"Annual":[546],"Meeting":[547],"2017;":[548],"2017":[549],"Apr":[550],"1-5;":[551],"Washington,":[552],"DC.":[553],"Philadelphia":[554],"(PA):":[555],"AACR;":[556],"Res":[558],"2017;77(13":[559],"Suppl):Abstract":[560],"nr":[561],"CT150.":[562],"doi:10.1158/1538-7445.AM2017-CT150":[563]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-08-08T00:00:00"}